AML3D Delivers Strong Revenue Growth and Expands U.S. Defence Order Book
AML3D Limited (ASX: AL3) has released its Quarterly Activities Report and Appendix 4C for the quarter ended 31 December 2025, highlighting strong growth in customer receipts and continued momentum in the U.S. market. Customer receipts for the quarter reached AU$2.3 million, representing a 360 per cent increase on the prior comparable period, driven by execution of the Company’s U.S. scale-up strategy. AML3D entered FY26 with AU$9 million in orders on hand and has since secured an additional AU$7.5 million, lifting total orders to be delivered in the current financial year to AU$16.5 million. The quarter included multiple ARCEMY® system orders from U.S. defence and industrial customers, while a Letter of Intent from the U.S. Department of the Navy continues to underpin a significant long-term opportunity within the Maritime Industrial Base.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
AML3D Delivers Strong Revenue Growth and Expands U.S. Defence Order Book
AML3D Limited (ASX: AL3) has released its Quarterly Activities Report and Appendix 4C for the quarter ended 31 December 2025, highlighting strong growth in customer receipts and continued momentum in the U.S. market. Customer receipts for the quarter reached AU$2.3 million, representing a 360 per cent increase on the prior comparable period, driven by execution of the Company’s U.S. scale-up strategy. AML3D entered FY26 with AU$9 million in orders on hand and has since secured an additional AU$7.5 million, lifting total orders to be delivered in the current financial year to AU$16.5 million. The quarter included multiple ARCEMY® system orders from U.S. defence and industrial customers, while a Letter of Intent from the U.S. Department of the Navy continues to underpin a significant long-term opportunity within the Maritime Industrial Base.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au